SciELO - Scientific Electronic Library Online

 
vol.39 número3Repercussão da pandemia de COVID-19 no diagnóstico e tratamento do câncer de mama em pacientes atendidas na Unidade de Mastologia do Hospital de ClínicasSistematização dos resultados dos primeiros dez anos do Tribunal de Ética Médica do Colégio Médico del Uruguay índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Links relacionados

Compartilhar


Revista Médica del Uruguay

versão impressa ISSN 0303-3295versão On-line ISSN 1688-0390

Resumo

SANTOS, Cecilia; MAGALLANES, Danilo; RUBINOS, Melina  e  DANZA, Álvaro. Obstetric and Perinatal Outcomes of Maternal COVID-19 Disease. Case-Control Study. Rev. Méd. Urug. [online]. 2023, vol.39, n.3, e204.  Epub 01-Set-2023. ISSN 0303-3295.  https://doi.org/10.29193/rmu.39.3.4.

Introduction:

Viral infections during pregnancy can lead to maternal and fetal complications. It is important to describe the maternal and fetal implications of COVID-19 disease.

Objetives:

To describe and analyze the characteristics of patients who experienced SARS-CoV-2 infection during gestation, and maternal and fetal outcomes.

Method:

A case-control study was conducted. All pregnant patients who presented SARS-CoV-2 infection and were hospitalized in a private healthcare institution (cases) during the period 1/03/2021 - 31/07/2021 were included in the study. Controls were selected from pregnant patients who were admitted during the same time but tested negative for SARS-CoV-2. Two controls were included for each case. The maternal variables considered were preterm labor, gestational diabetes, preeclampsia, (severe or non-severe) preeclampsia, fetal death, fetal growth restriction, placental abruption. The neonatal variables considered were vital status, newborn weight, one-minute and five-minute Apgar scores, need for admission to a specialized neonatal care unit, and length of stay in days. COVID-19 tests for the newborn and their condition at discharge were recorded.

Results:

Maternal demographic characteristics were comparable in both groups. Twenty-one (55%) obstetric complications were observed in the case group, and 117 (44.7%) in the control group; OR= 4.2 (95% CI: 1.9-9.7). Twenty-one (30.8%) neonatal complications were observed in the case group, and 3 (3.8%) in the control group; OR= 11.2 (95% CI: 2.9-42.9). The case group was associated with a lower likelihood of being vaccinated; OR = 0.3 (95% CI: 0.13-0.75).

Conclusions:

We report an increased risk of adverse maternal and neonatal outcomes associated with SARS-CoV-2 virus infection. Vaccination proves to be a valuable tool against this viral infection.

Palavras-chave : COVID-19; Pregnancy; Infectious complications of pregnancy; Newborn.

        · resumo em Português | Espanhol     · texto em Espanhol     · Espanhol ( pdf )